AstraZeneca Aktie
166,55
EUR
-0,50
EUR
-0,30
%
166,40
EUR
-0,20
EUR
-0,12
%
Erwachsen handeln.
Mit dem Broker, der Top-Insights, geprüfte Analysen
und Trading ab 0 € vereint (zzgl. Spreads).
Werbung
AstraZeneca Aktie Analyse
| 02.07.18 | AstraZeneca Neutral | UBS AG | |
| 25.06.18 | AstraZeneca Neutral | UBS AG | |
| 23.05.18 | AstraZeneca Hold | S&P Capital IQ | |
| 22.05.18 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 18.05.18 | AstraZeneca Neutral | UBS AG | |
| 26.02.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.02.18 | AstraZeneca Hold | S&P Capital IQ | |
| 09.02.18 | AstraZeneca Hold | S&P Capital IQ | |
|
Werbung
|
|||
| 06.02.18 | AstraZeneca Neutral | UBS AG | |
| 16.01.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 15.01.18 | AstraZeneca Neutral | UBS AG | |
| 08.01.18 | AstraZeneca Neutral | UBS AG | |
| 01.12.17 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 30.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 10.11.17 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 10.11.17 | AstraZeneca Hold | S&P Capital IQ | |
| 09.11.17 | AstraZeneca Neutral | UBS AG | |
| 03.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 01.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 23.10.17 | AstraZeneca Neutral | UBS AG | |
| 20.10.17 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 18.10.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 16.10.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.10.17 | AstraZeneca Neutral | UBS AG | |
| 18.09.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 13.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 11.09.17 | AstraZeneca Neutral | UBS AG | |
| 11.09.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 11.09.17 | AstraZeneca Neutral | BNP PARIBAS | |
| 11.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 11.09.17 | AstraZeneca Neutral | Credit Suisse Group | |
| 08.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 01.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 31.08.17 | AstraZeneca Neutral | UBS AG | |
| 24.08.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.08.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 01.08.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 01.08.17 | AstraZeneca Neutral | UBS AG | |
| 31.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 28.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 28.07.17 | AstraZeneca neutral | Credit Suisse Group | |
| 27.07.17 | AstraZeneca Hold | S&P Capital IQ | |
| 27.07.17 | AstraZeneca Neutral | UBS AG | |
| 21.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 13.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 12.07.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 27.06.17 | AstraZeneca Neutral | UBS AG | |
| 16.06.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.06.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 24.05.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
Werbung
Werbung